Personal information

No personal information available

Activities

Collapse all

Employment (1)

Yale University: New Haven, CT, US

2017-07-01 to present | Assistant Professor (Pharmacology)
Employment
Source: Self-asserted source
Daryl Klein

Education and qualifications (1)

University of Pennsylvania: Philadelphia, PA, US

2000-09-02 to 2009-05-25 | M.D./Ph.D.
Education
Source: Self-asserted source
Daryl Klein

Works (21)

A ligand divided: antagonist, agonist and analog control

Biochemical Journal
2017 | Journal article
Source: Self-asserted source
Daryl Klein

Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation

Cell
2017 | Journal article
Source: Self-asserted source
Daryl Klein

Discovery of the first pathogenic human EPO mutation provides mechanistic insight into cytokine signaling

2016 | Other
Source: Self-asserted source
Daryl Klein

Correction: Sequential conformational rearrangements in flavivirus membrane fusion

eLife
2015 | Journal article
Source: Self-asserted source
Daryl Klein

Structural basis of neurohormone perception by the receptor tyrosine kinase Torso

Molecular cell
2015 | Journal article
Source: Self-asserted source
Daryl Klein

Sequential conformational rearrangements in flavivirus membrane fusion

Elife
2014 | Journal article
Source: Self-asserted source
Daryl Klein

Structure of a dengue virus envelope protein late-stage fusion intermediate

Journal of virology
2013 | Journal article
Source: Self-asserted source
Daryl Klein

Structural basis for negative cooperativity in growth factor binding to an EGF receptor

Cell
2010 | Journal article
Source: Self-asserted source
Daryl Klein

ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor

Nature
2009 | Journal article
Source: Self-asserted source
Daryl Klein

Structural basis for EGFR ligand sequestration by Argos

The FASEB Journal
2009 | Journal article
Source: Self-asserted source
Daryl Klein

Biochemical and structural studies of a secreted antagonist of the epidermal growth factor receptor

2008 | Journal article
Source: Self-asserted source
Daryl Klein

Structural basis for EGFR ligand sequestration by Argos

Nature
2008 | Journal article
Source: Self-asserted source
Daryl Klein

Computational analysis of EGFR inhibition by Argos

Developmental biology
2005 | Journal article
Source: Self-asserted source
Daryl Klein

Computational, Genetic, and Biochemical Analysis of Egfr Control by Multiple Feedback Loops

The 2005 Annual Meeting
2005 | Conference paper
Source: Self-asserted source
Daryl Klein

Mechanisms of Inhibition of the Epidermal Growth Factor Receptor: Implications for Novel Anti-Cancer Therapies

2005 | Report
Source: Self-asserted source
Daryl Klein

Argos inhibits epidermal growth factor receptor signalling by ligand sequestration

Nature
2004 | Journal article
Source: Self-asserted source
Daryl Klein

High-affinity binding of a FYVE domain to phosphatidylinositol 3-phosphate requires intact phospholipid but not FYVE domain oligomerization

Biochemistry
2001 | Journal article
Source: Self-asserted source
Daryl Klein

The monomer of the yeast transcriptional activator GCN4 recognizes its dimer binding DNA target sites without dimerization

Thermochimica acta
2000 | Journal article
Source: Self-asserted source
Daryl Klein

Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains

Journal of Biological Chemistry
1998 | Journal article
Source: Self-asserted source
Daryl Klein

The pleckstrin homology domains of dynamin isoforms require oligomerization for high affinity phosphoinositide binding

Journal of Biological Chemistry
1998 | Journal article
Source: Self-asserted source
Daryl Klein

Abstract/Details

Journal article
Source: Self-asserted source
Daryl Klein
How many people are using ORCID?